Name: ZPHC Retatrutide AQ -30 MG / PEN -30 MG / 3 ML PEN
Brand: ZPHC
SKU: 7728
Price: 1850.00 AED
Availability: InStock

🧴 Retatrutide AQ – 30 MG / 3 mL Pen – ZPHC PHARMA

🧪 Product Type

Advanced Peptide – Triple Receptor Agonist (GLP-1 / GIP / Glucagon)

Active Ingredient: Retatrutide

Concentration: 30 MG / 3 mL

Form: Pre-filled injectable pen (aqueous solution)

Manufacturer: ZPHC PHARMA

📄 Description

Retatrutide AQ by ZPHC PHARMA is a next-generation injectable peptide therapy formulated in a ready-to-use prefilled pen, containing 30 MG of Retatrutide in 3 mL of aqueous solution. It functions as a triple receptor agonist, simultaneously targeting:

GLP-1 (Glucagon-like peptide-1)
GIP (Gastric inhibitory peptide)
Glucagon receptors

This unique triple action has demonstrated promising results in metabolic research, especially in obesity management, type 2 diabetes, and energy regulation.

✅ Key Benefits

🔥 Powerful Fat-Burning Potential
Increases metabolic rate and promotes lipolysis
🍽️ Appetite Suppression & Satiety
Helps reduce caloric intake through central appetite regulation
💉 Convenient Pre-Filled Pen
Easy and precise administration without reconstitution
📉 Improved Blood Glucose Control
Enhances insulin sensitivity and lowers fasting glucose
⚙️ Supports Weight Management & Energy Balance
Ideal for research involving complex metabolic disorders

⚙️ Mechanism of Action

Retatrutide mimics multiple gut-derived hormones, activating receptors involved in:

Glucose homeostasis
Fat metabolism
Energy expenditure
Appetite regulation

This synergy helps deliver comprehensive metabolic modulation in experimental models.

💉 Suggested Research Use (For Laboratory Research Only)

Dosage: Varies based on protocol (typically once weekly)
Administration: Subcutaneous injection via prefilled pen
No mixing or preparation required
Monitor for metabolic markers, appetite response, and body composition changes